Corcept Therapeutics CORT Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's income tax?
- Corcept Therapeutics (CORT) reported income tax of -$12.95M in Q1 2026.
- How has Corcept Therapeutics's income tax changed year-over-year?
- Corcept Therapeutics's income tax decreased by 18.5% year-over-year, from -$10.93M to -$12.95M.
- What is the long-term trend for Corcept Therapeutics's income tax?
- Over 4 years (2021 to 2025), Corcept Therapeutics's income tax has grown at a 27.7% compound annual growth rate (CAGR), from $12.49M to -$33.19M.
- What does income tax mean?
- The total amount of tax a company owes on its profits.
- How do you interpret income tax?
- Fluctuations often reflect changes in statutory tax rates, tax credits, or the utilization of deferred tax assets.
- How does income tax compare across companies?
- Highly dependent on the company's geographic footprint and specific tax planning strategies.